X4 Pharmaceuticals (XFOR) Gains from Investment Securities (2017 - 2024)
X4 Pharmaceuticals (XFOR) posted Gains from Investment Securities of $1.9 million for Q3 2024, up 109.22% on a QoQ basis from -$20.2 million in Q2 2024, and up 107.41% year-over-year from $898714.3 in Q4 2023.
X4 Pharmaceuticals (XFOR) Gains from Investment Securities (2017 - 2024) Analysis & Trends
X4 Pharmaceuticals' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $1.9 million for Q3 2024.
- Quarterly Gains from Investment Securities rose 107.41% year-over-year to $1.9 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was -$29.8 million (down 3905.38% YoY) and the FY2017 annual result came in at $31000.0, up 179.49% from the prior year.
- Gains from Investment Securities was $1.9 million for Q3 2024 at X4 Pharmaceuticals, up from -$20.2 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $29.9 million in Q2 2023 and bottomed at -$25.2 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,831.58 Bn | 66,831.30 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 976.78 Bn | 976.78 Bn | - |
| 4 | BeOne Medicines | 471.48 Bn | 466.69 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.78 Bn | 114.53 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.54 Bn | 34.53 Bn | 959.66 Mn |
| 10 | X4 Pharmaceuticals | 167.69 Mn | -49.36 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.86 Mn |
| Jun 30, 2024 | -20.22 Mn |
| Jun 30, 2024 | -20.22 Mn |
| Mar 31, 2024 | 13.76 Mn |
| Mar 31, 2024 | 13.76 Mn |
| Sep 30, 2023 | -25.16 Mn |
| Sep 30, 2023 | -25.16 Mn |
| Jun 30, 2023 | 29.86 Mn |
| Jun 30, 2023 | 29.86 Mn |
| Mar 31, 2023 | -5.44 Mn |
| Mar 31, 2023 | -5.44 Mn |
| Dec 31, 2017 | 47,000.00 |
| Dec 31, 2017 | 47,000.00 |
| Sep 30, 2017 | -5,000.00 |
| Sep 30, 2017 | -5,000.00 |
| Jun 30, 2017 | -11,000.00 |
| Jun 30, 2017 | -11,000.00 |